nad+glp-1 GLP1 receptor agonists are looking like longevity drugs. A new study reports that drug-induced improvements in bone mass are mediated by the NAD-dependent SIRT1 enzyme. If so, could NAD boosters work with NAD+ — Compounded Injection (Olympia)

That's why our model leads with behavior change, supported by medication only when clinically appropriate

The association between triglyceride and coronary heart disease

When you're on GLP-1s, your body is going through a significant transition, and having the right support makes all the difference.Maven Clinic connects you with specialists in women's metabolic health

The similarity can be explained by the presence of similar structural moieties in the terminal parts of both moleculesGHRP1 has the same peptide sequence as ipamorelin with the inclusion of LAlaLTrp in the middle of the structure, and on the other hand, ipamorelin has an abundant methyl group at the LAla end